RANOLAZINE
NDC 72319-021, RANOLAZINE, tablet, film coated, extended release, from i3 Pharmaceuticals, LLC.
- Product NDC
- 72319-021
- Status
- Listed
- Labeler
- i3 Pharmaceuticals, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213517
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72319-021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RANOLAZINE500 mg/1
Pharmacologic classes
Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72319-021-02 | 72319002102 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72319-021-02) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/de3185bf-448a-15f7-e053-2995a90a9a2eNADAC price for package 72319002102
GET /v1/drugs/nadac/72319002102
Use it
Look up 72319-021 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72319-021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72319-021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.